APOLLOHOSP

Apollo Hospitals Enterprise Share Price Apollo Hospitals Enterprise

₹6,113.2
-23.35 (-0.38%)
  • Advice
  • Hold
19 March, 2024 17:06 BSE: 508869 NSE: APOLLOHOSPISIN: INE437A01024

Start SIP in Apollo Hospitals Enterprise

Start SIP

Apollo Hospitals Enterprise Performance

Day Range

  • Low 6,034
  • High 6,126
₹ 6,113

52 Week Range

  • Low 4,168
  • High 6,874
₹ 6,113
  • Open Price6,077
  • Previous Close6,137
  • Volume542392

Apollo Hospitals Enterprise Share Price

  • Over 1 Month -7.38%
  • Over 3 Month 11.18%
  • Over 6 Month 20.45%
  • Over 1 Year 40.65%

Apollo Hospitals Enterprise Key Statistics

P/E Ratio 111.4
PEG Ratio 34.6
Market Cap Cr 87,899
Price to Book Ratio 13.5
EPS 74.6
Dividend 0.2
Relative Strength Index 46.34
Money Flow Index 23.29
MACD Signal -49.89
Average True Range 154.67
Apollo Hospitals Enterprise Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,8241,8671,6881,641
Operating Expenses Qtr Cr 1,3741,3871,2711,218
Operating Profit Qtr Cr 450479418423
Depreciation Qtr Cr 97939397
Interest Qtr Cr 61606161
Tax Qtr Cr 81966782
Net Profit Qtr Cr 263295214227
IndicatorMar 2023
Total Revenue Annual Cr 6,676
Operating Expenses Annual Cr 4,843
Operating Profit Annual in Cr 1,682
Depreciation Cr 367
Interest Annual Cr 239
Tax Annual Cr 143
Net Profit Annual Cr 1,085
IndicatorMar 2023
Cash from Operating Activity Annual Cr 1,225
Cash from Investing Activity Annual Cr -589
Cash from Financing Annual Activity Cr -779
Net Cash Flow Annual Cr -143
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 6,925
Fixed Assets Annual Cr 5,174
Total Non Current Assets Annual Cr 7,630
Total Current Assets Annual Cr 3,151
Total Assets Annual Cr 10,780
IndicatorMar 2023
Book Value Per Share Annual Rs 482
ROE Annual % 16
ROCE Annual % 15
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 28
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 4,8514,8474,4184,302
Operating Expenses Qtr Cr 4,2374,2193,9093,814
Operating Profit Qtr Cr 614628509488
Depreciation Qtr Cr 167163167159
Interest Qtr Cr 11311110695
Tax Qtr Cr 10913097108
Net Profit Qtr Cr 245233167145
IndicatorMar 2023
Total Revenue Annual Cr 16,703
Operating Expenses Annual Cr 14,563
Operating Profit Annual in Cr 2,050
Depreciation Cr 615
Interest Annual Cr 381
Tax Annual Cr 256
Net Profit Annual Cr 819
IndicatorMar 2023
Cash from Operating Activity Annual Cr 1,377
Cash from Investing Activity Annual Cr -871
Cash from Financing Annual Activity Cr -633
Net Cash Flow Annual Cr -127
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 6,197
Fixed Assets Annual Cr 8,144
Total Non Current Assets Annual Cr 10,091
Total Current Assets Annual Cr 4,337
Total Assets Annual Cr 14,428
IndicatorMar 2023
Book Value Per Share Annual Rs 454
ROE Annual % 13
ROCE Annual % 14
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 13

Apollo Hospitals Enterprise Technicals

EMA & SMA

Current Price
₹6,113.2
-23.35 (-0.38%)
pointer
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹6,193.18
  • 50 Day
  • ₹6,147.27
  • 100 Day
  • ₹5,895.71
  • 200 Day
  • ₹5,522.98
  • 20 Day
  • ₹6,282.42
  • 50 Day
  • ₹6,238.35
  • 100 Day
  • ₹5,820.83
  • 200 Day
  • ₹5,430.15

Apollo Hospitals Enterprise Resistance and Support

PIVOT
₹6,086.72
Resistance
First Resistance 6,194.78
Second Resistance 6,253.02
Third Resistance 6,361.08
RSI 46.34
MFI 23.29
MACD Single Line -49.89
MACD -79.99
Support
First Resistance 6,028.48
Second Resistance 5,920.42
Third Resistance 5,862.18

Apollo Hospitals Enterprise Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 424,603 24,474,117 57.64
Week 498,110 28,945,149 58.11
1 Month 606,610 35,656,550 58.78
6 Month 462,129 24,118,535 52.19

Apollo Hospitals Enterprise Result Highlights

Apollo Hospitals Enterprise Synopsis

NSE-Medical-Hospitals

Apollo Hospitals is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 6524.80 Cr. and Equity Capital is Rs. 71.90 Cr. for the Year ended 31/03/2023. Apollo Hospitals Enterprise Ltd. is a Public Limited Listed company incorporated on 05/12/1979 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TN1979PLC008035 and registration number is 008035.
Market Cap 87,354
Sales 7,020
Shares in Float 10.21
No of funds 1298
Yield 0.24
Book Value 12.74
U/D Vol ratio 1.3
LTDebt / Equity 22
Alpha 0.06
Beta 0.7

Apollo Hospitals Enterprise

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 29.33%29.33%29.33%29.33%
Mutual Funds 13.92%13.19%12.04%11.37%
Insurance Companies 4.05%4.28%4.23%5.49%
Foreign Portfolio Investors 46.25%46.15%47.93%46.96%
Financial Institutions/ Banks
Individual Investors 3.7%4.03%3.89%4.05%
Others 2.75%3.02%2.58%2.8%

Apollo Hospitals Enterprise Management

Name Designation
Dr. Prathap C Reddy Founder & Executive Chairman
Mrs. Preetha Reddy Executive Vice Chairperson
Mrs. Shobana Kamineni Executive Vice Chairperson
Mrs. Suneeta Reddy Managing Director
Mrs. Sangita Reddy Joint Managing Director
Mr. M B N Rao Independent Director
Mr. Vinayak Chatterjee Independent Director
Dr. Som Mittal Independent Director
Mrs. V Kavitha Dutt Independent Director
Dr. Murali Doraiswamy Independent Director
Mrs. Rama Bijapurkar Independent Director

Apollo Hospitals Enterprise Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Apollo Hospitals Enterprise Corporate Action

Date Purpose Remarks
2024-02-08 Quarterly Results & Interim Dividend
2023-11-09 Quarterly Results
2023-08-11 Quarterly Results
2023-05-30 Audited Results & Final Dividend
2023-02-14 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-02-20 INTERIM Rs.6.00 per share(120%)Interim Dividend
2023-08-19 FINAL Rs.9.00 per share(180%)Final Dividend
2023-02-24 FINAL Rs.6.00 per share(120%)Interim Dividend

About Apollo Hospitals Enterprise

Company Brief

Widely known for operating a nationwide legendary chain of hospitals, the Apollo group is a modern healthcare giant that also runs several diagnostic centres, pharmacies and telehealth clinics under its umbrella. Over the years, the group has forayed into other non-core healthcare domains like health insurance, medical colleges and medvarsity, nursing and hospital management, global projects consultancy and research. 
The prominent brands under its roof include Apollo Munich Health Insurance, Apollo Pharmacy, Life Studio, Apollo Spectra, and Apollo Cradle, besides Apollo Clinic and Hospitals.

Apollo Hospitals was founded by Dr Prathap C Reddy, with its first-ever branch established in Chennai in 1983 and inaugurated by the then president Shri Giani Zail Singh. In the 1980's it had declared its maiden dividend of 10% and established a branch in Hyderabad. Since then, it has set up numerous branches in New Delhi, Bangalore, Kolkata, Mumbai, Noida, Ahmedabad, and Bhubaneshwar, among other Indian cities. It also has a branch in Dhaka, Bangladesh.
One of its early trailblazing endeavours was telemedicine services in 2000 at Aragonda village in Chittoor, Andhra Pradesh. In 2012, 38% stake of the group's healthcare BPO segment was disposed off to Sutherland Global Services at a valuation of INR 225 crores. Further, in early 2020, the majority stake of its insurance subsidiary Apollo Munich Health Insurance was acquired by HDFC for INR 1,495.81 crores.
Over the years, the group has earned multiple international recognitions in healthcare standards, biotechnological breakthroughs and innovative medical care. It has 8 JCIA and 30 NABH (National Accreditation Board for Hospitals) accredited hospitals, not to mention its state-of-the-art speciality wings, including 25 Heart institutes, several cancer hospitals and organ transplant centres.

Board, Management and Auditors

Board of Directors

The board of directors manages the group in the parent company under the able leadership of founder chairman Dr Prathap Chandra Reddy - a Padma Bhushan and Padma Vibhushan awardee. The board consists of:

Executive Director - Prathap C. Reddy 

Dr Reddy is the visionary founder of the Apollo enterprise, responsible for ushering in an era of world-class medical facilities and treatments in India. He is the torchbearer of modern healthcare in this country and is the driving force behind the group's success.

Executive Vice Chairperson - Dr Preetha Reddy

A member of the founding family Dr Reddy is known for her immense contribution to the furtherance of the Apollo group and the betterment of the country through her philanthropic ventures and able governance.

 Executive Vice Chairperson - Ms Shobana Kamineni

Another member of the founding family has advocated the operation of integrated digital-first healthcare services in the country through Apollo 24/7. Presently Ms Kamineni leads the country's largest pharmacy chain, Apollo Pharmacy, with a countrywide network of over 4,000+ stores and 30,000+ employees.

Ms Suneeta Reddy -  Managing Director

Ms Reddy is at the forefront of the group's finance and strategy functions and serves on various subsidiaries' boards.

Dr Sangita Reddy- Joint Managing Director

As a joint MD, Dr Reddy spearheads the Global Healthcare service delivery and is an honourable member of the World Economic Forum.

Independent Directors

M B N Rao is the lead independent director, and Vinayak Chatterjee, Murali Doraiswamy, V Kavitha Dutt, and Som Mittal are eminent independent directors on the board who oversee the corporate governance of the company and look into the interest of the investors and public.

Auditors

The financials are audited by Deloitte Haskins & Sells LLP. It is one of the largest big4 accounting firm networks headquartered in England. They have been auditing the financials of the group from the financial year ending March 2017.

Market Capitalisation and Stock Information

Apollo Enterprise Ltd., went public in the year 1979. Consequently, it was listed in the NSE in January 1996, followed by BSE and several other exchanges. Since then, the stock has performed well and even stood out as the top performer in its peer groups in recent times. Let's look at some of the facts and figures:

●   The TTQ or Total Traded Quantity of its stock is 0.18 Lakhs.
●  The Face Value of shares is INR 5 each.
●  The stock is part of the S&P BSE 100 Index.

Shareholding Pattern

Out of the total stake, FIIs held 50.81%, Other Domestic Institutions 6.51%, Mutual Funds 5.94%, and Retail and Other investors held 7.41% of the company's equity shares.

The top mutual funds that have invested more than 2% of their AUM in the stock are Nippon India Pharma Fund, IDFC Balanced Advantage Fund, LIC MF Large Cap Fund and Sundaram Services Fund.

Corporate Social Responsibility Information

Steered by Dr Reddy, the founder and chairman of the group Apollo has been an exemplar in philanthropic collaborations and endeavours. The group's Total Health Cycle philosophy is: to 'screen, diagnose, treat, educate, and empower.' It successfully runs 3 philanthropic and humanitarian programs that aim at the economic and social prosperity of the underprivileged.

Total Health Program

This CSR model aims to enhance the mental, physical, social, ecological and spiritual health of individuals and the community at large. It directs its activities toward the society's comprehensive welfare and is mostly concentrated in the rural areas of Andhra Pradesh and Telangana.

Billion Hearts Beating Foundation

This non-profit organisation which runs several charitable projects for the elderly, public servants and healthcare workers, contributes by way of medicine supply and organisation of free healthcare camps for the beneficiaries. It also operates some critical care units in areas of public interest.

The SACHi Initiative

SACHi, on the other hand, is a child-focused non-profit initiative that fights for causes such as equal rights and quality healthcare for children. Over the years, it has provided free heart treatments, medicines and supplements to numerous children's homes and orphanages. It continues to pledge its services to touch the lives of many more children in the times to come.

Financial Information

Top Line

Over the last 5 years, the audited financial statements show a leap of INR 6420 crores in the Apollo group's total revenue. The revenue can be segregated as - 56% from core healthcare services and 9% from Apollo Health and Lifestyle, including Clinics, Diagnostic Centres, Dental, Dialysis and Fertility centres. Another 35% comes from the Pharmacy Distribution.

Bottom Line

On the other hand, the profit recorded has grown exponentially from Rs. 117 crores by a whopping 802.5% over the course of 5 years. The highest growth can be seen in the financial year 2021-22, when the bottom line grew 10 times. This can be attributed to a significant increase in revenue with a reduction in selling, general and administrative expenses.

 

 

Apollo Hospitals Enterprise FAQs

What is Share Price of Apollo Hospitals Enterprise ?

Apollo Hospitals Enterprise share price is ₹6,113 As on 19 March, 2024 | 16:52

What is the Market Cap of Apollo Hospitals Enterprise ?

The Market Cap of Apollo Hospitals Enterprise is ₹87898.5 Cr As on 19 March, 2024 | 16:52

What is the P/E ratio of Apollo Hospitals Enterprise ?

The P/E ratio of Apollo Hospitals Enterprise is 111.4 As on 19 March, 2024 | 16:52

What is the PB ratio of Apollo Hospitals Enterprise ?

The PB ratio of Apollo Hospitals Enterprise is 13.5 As on 19 March, 2024 | 16:52

What is the ROE of Apollo Hospitals Enterprise?

The ROE of Apollo Hospitals Enterprise is 3% which is fair but needs improvement.

When was Apollo Hospitals Enterprise founded?

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned as the architect of modern healthcare in India.

What is the stock price CAGR of Apollo Hospitals Enterprise?

The stock price CAGR of Apollo Hospitals Enterprise for 10 Years is 23%, 5 Years is 33%, 3 Years is 55%, 1 Year is 98%.

Is it a good time to invest in Apollo Hospital Enterprise?

Apollo Hospital Enterprise has an operating revenue of Rs. 13,105.07 Cr. on a trailing 12-month basis. Annual revenue de-growth of -6% needs improvement, Pre-tax margin of 2% needs improvement. The company has a debt to equity of 54%, which is a bit higher. Several analysts have a Buy rating on the stock.

How to buy Apollo Hospitals Enterprise Ltd. shares?

You can easily buy the shares of Apollo Hospitals Enterprise Ltd., by registering at 5Paisa and by setting up a Demat Account in your name.
 

Q2FY23